Overview

Azilsartan in Chinese Patients With Mild and Moderate Hypertension

Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
A phase 3 clinical study to evaluate the safety and efficacy of Azilsartan in Chinese hypertension patients
Phase:
Phase 3
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Treatments:
Azilsartan medoxomil
Olmesartan
Olmesartan Medoxomil